“The lower the amount of an antibody you can deliver to someone, the easier it will be to manufacture a treatment, and the ...
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
News Medical on MSN8d
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma, other inflammatory diseasesCurrent asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...
News Medical on MSN5d
New human antibody shows promise for Ebola virus treatmentNew research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...
AZoLifeSciences on MSN1d
As dengue spreads, researchers discover a clue to fighting the virusThis research comes as dengue-carrying mosquitos expand their territory into new regions, including Southern California.
Two therapeutic "cocktails" could stop immune cells from overreacting to allergens, providing long-lasting asthma relief.
1don MSN
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback